NCT04674683 2025-09-24Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced MelanomaHUYABIO International, LLC.Phase 3 Active not recruiting450 enrolled